Reasons for medical care outpatient who died from “unspecified” diseases of the nervous system

The number of patients with multiple diseases is increasing globally, leading to challenges in determining the primary cause of death (PCD). Often, the medical death certificate (MDC) lists nosologically unjustified codes as the PCD. The aim of this study is to investigate the reasons for outpatient medical visits by patients whose PCD after death was recorded as unspecified encephalopathy (G93.4), cerebral cyst (G93.0), and senile degeneration of the brain (G31.1); and to discuss possible reasons for these codes being listed as the PCD. Material and methods. Data from the electronic database of the Main Directorate of the Civil Registry Office of the Moscow Region (USR system of the Civil Registry Office of the Moscow Region) and electronic medical records (EMR) from outpatient clinics (APU) for 2020–2021. In total, 15,741 cases were registered in the MCC with codes G93.4, G93.0 and G31.1 indicated as UCD, of which 11,678 (74.2%) applied to the APU. Results. There were no recorded instances where the sole reason for outpatient visits was codes G93.4, G93.0, and G31.1. Nearly 80% of patients who had one of these three codes listed as PCD after death had visited outpatient clinics more than once. The average number of outpatient visits for any reason was 6.8 ± 8.8. Almost 70% had registered cardiovascular diseases (CVD) (of which 42.9% were cerebrovascular diseases), cancer accounted for 7.2%; diabetes mellitus for 5.3%; and nervous system diseases (NSD) for 8.8%; while 11% were related to COVID-19. The overwhelming majority of deaths coded as PCD G31.1 and G93.4 occurred in individuals aged 75 to 95 years (84% and 77.5%, respectively), while for code G93.0 it was 63.2%. In each subgroup of deceased individuals, women predominated, with an average age (84.6 ± 8.1 years) higher than that of men (78.5 ± 10.8 years). Conclusions. Codes G93.4, G93.0, and G31.1 as PCD are predominantly used in older age groups against a backdrop of repeated outpatient visits and multimorbidity. It is insufficient to simply prohibit their use; a coordinated position among specialists is necessary to select the appropriate PCD (and corresponding code) in cases of non-life-threatening multimorbid pathology in elderly individuals

1. Kakorina E.P., Samorodskaya I.V., Kotov S.V. Mortality rates for men and women from cerebrovascular and nervous diseases in the regions of Russia in 2013 and 2022. National Health Care (Russia). 2024;5(1):29–37. (In Russian). DOI: 10.47093/2713-069X.2024.5.1.29-37

2. Samorodskaya I.V., Kakorina E.P., Chernyavskaya T.K., Kotov S.V. Diseases of the nervous system as the underlying cause of death. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(1):135142. (In Russian). DOI: 10.17116/jnevro2024124011135

3. Chukayeva I.I., Samorodskaya I.V., Larina V.N. The prevalence of multimorbidity: discussion about the terminology, registration and its eff ect on patient’s health care utilization. Ter. Arkh. 2018;90(8):125–130. (In Russian). DOI: 10.26442/terarkh2018908125-130

4. Drapkina O.M., Shutov A.M., Efremova E.V. Comorbidity, multimorbidity, dual diagnosis — synonyms or diff erent terms? Cardiovascular Therapy and Prevention. 2019;18(2):65–69. (In Russian). DOI: 10.15829/1728-8800-2019-2-65-69

5. Skou S.T., Mair F.S., Fortin M., Guthrie B., Nunes B.P., Miranda J.J. et al. Multimorbidity. Nat. Rev. Dis. Primers. 2022;8(1):48. DOI: 10.1038/s41572-022-00376-4

6. Arshadipour A., Thorand B., Linkohr B., Ladwig K.H., Heier M., Peters A. Multimorbidity patterns and mortality in older adults: Results from the KORA-Age study. Front. Nutr. 2023;10:1146442. DOI: 10.3389/fnut.2023.1146442

7. Xiao L.X., Wang Z.Y., Li J.T., Wang H.M., Hao Y.M., Zhou P. et al. Association of cardiometabolic multimorbidity with allcause and cardiovascular disease mortality among Chinese hypertensive patients. J. Geriatr. Cardiol. 2024;21(2):211-218. DOI: 10.26599/1671-5411.2024.02.003

8. Canoy D., Tran J., Zottoli M., Ramakrishnan R., Hassaine A., Rao S. et al. Association between cardiometabolic disease multimorbidity and all-cause mortality in 2 million women and men registered in UK general practices. BMC Med. 2021;19(1):258. DOI: 10.1186/s12916- 021-02126-x

9. Samorodskaya I.V., Semenov V.Yu. Mortality from arterial hypertension in the regions of the Russian Federation in the period from 2013 to 2019. Kardiologiia. 2021;61(12):59–65. (In Russian). DOI: 10.18087/cardio.2021.12.n1643

10. Coelho, Juliana Chaves, Ferretti-Rebustini, Renata Eloah de Lucena, Suemoto, Claudia Kimie, Leite, Renata Elaine Paraizo, Jacob-Filho, Wilson, & Pierin, Angela Maria Geraldo. (2019). Hypertension is the underlyinGcause of death assessed at the autopsy of individuals. Revista da Escola de Enfermagem da USP. 2019;53:e03457. DOI: 10.1590/s1980-220x2018006103457

11. Kotov S.V., Isakova E.V., Kolchu I.G., Belkina S.N. The infl uence of modifi able risk factors for stroke on the results of systemic thromboytic therapy in patients in the acute period of ischemic stroke. Annals of Clinical and Experimental Neurology. 2021;15(1):21–31. (In Russian). DOI: 10.25692/ACEN.2021.1.3

12. Kulesh A.A,. Emelin A.Y., Bogolepova A.N., Doronina O.B., Zakharov V.V., Kolokolov O.V. et al. Clinical manifestations and issues of diagnosis of chronic cerebrovascular disease (chronic cerebral ischemia) at an early (predementia) stage. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2021;13(1):4–12. (In Russian). DOI: 10.14412/2074-2711-2021-1-4-12

13. Asai K., Osugi Y. Increased Mortality of “Died of Old Age” in Japan. J. Gerontol. Geriatr. Med. 2022;8:135. DOI: 10.24966/GGM8662/100135

14. Tkacheva O.N., Kotovskaya Yu.V., Runikhina N.K., Frolova E.V., Naumov A.V., Vorobyeva N.M. et al. Senile asthenia: clinical recommendations. Russian Journal of Geriatric Medicine. 2020;1:11–46. (In Russian). DOI: 10.37586/2686-8636-1-2020-11-46

15. Proietti M, Cesari M. Frailty: What Is It? Adv. Exp. Med. Biol. 2020;1216:1–7. DOI: 10.1007/978-3-030-33330-0_1

16. Meslé, F., Vallin, J. Causes of death at very old ages, Including for supercentenarians. Exceptional Lifespans. 2021;69–84. DOI: 10.1007/978-3-030-49970-9_7

17. Allison R 2nd, Assadzandi S, Adelman M. Frailty: Evaluation and Management. Am. Fam. Physician. 2021;103(4):219–226.

18. Long, N.H. (2023). At the End of Life: Health, Death, and Cultural Practices. In: Liamputtong, P. (eds) Handbook of Social Sciences and Global Public Health. Springer, Cham. https://doi.org/10.1007/978-3-031-25110-8_135